EX-10.17 4 dex1017.htm PROCESS DEVELOPMENT AND MFG SERVICES AGREEMENT - LONZA BIOLOGICS, INC. [*] = Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been...Development and MFG Services Agreement • May 5th, 2020 • Delaware
This Process Development and Manufacturing Services Agreement (this “Agreement”) is effective as of March 28, 2008 (the “Effective Date”), by and between Bayhill Therapeutics, Inc., a Delaware corporation (“Client”), and Lonza Biologics, Inc., a Delaware corporation (“LONZA”) (each, a “Party” and together the “Parties”).
